{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T10:32:55Z","timestamp":1791196375997,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","schres-journal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.schres.2015.08.019","type":"journal-article","created":{"date-parts":[[2015,9,2]],"date-time":"2015-09-02T23:08:01Z","timestamp":1441235281000},"page":"456-460","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":95,"title":["Associations of high sensitivity C-reactive protein levels in schizophrenia and comparison groups"],"prefix":"10.1016","volume":"168","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1012-722X","authenticated-orcid":false,"given":"Jamie","family":"Joseph","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Depp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Averria Sirkin","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca E.","family":"Daly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle K.","family":"Glorioso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barton W.","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilip V.","family":"Jeste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.schres.2015.08.019_bb0005","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.psychres.2008.06.010","article-title":"Association of blood levels of C-reactive protein with clinical phenotypes in Arab schizophrenic patients","volume":"169","author":"Akanji","year":"2009","journal-title":"Psychiatry Res."},{"issue":"10","key":"10.1016\/j.schres.2015.08.019_bb0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0111882","article-title":"Mortality among people with severe mental disorders who reach old age: a longitudinal study of a community-representative sample of 37,892 men","volume":"9","author":"Almeida","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.schres.2015.08.019_bb0015","series-title":"Scale for the Assessment of Negative Symptoms (SANS)","author":"Andreasen","year":"1983"},{"key":"10.1016\/j.schres.2015.08.019_bb0020","series-title":"Scale for the Assessment of Positive Symptoms (SAPS)","author":"Andreasen","year":"1984"},{"issue":"3","key":"10.1016\/j.schres.2015.08.019_bb9200","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.biopsych.2009.08.040","article-title":"Antipsychotic dose equivalents and dose-years: A standardized method for comparing exposure to different drugs","volume":"67","author":"Andreasen","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.schres.2015.08.019_bb0025","series-title":"Delis\u2013Kaplan Executive Function Scale (D\u2013KEFS): Examiner's manual","author":"Delis","year":"2001"},{"issue":"2","key":"10.1016\/j.schres.2015.08.019_bb0030","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.socscimed.2008.03.038","article-title":"Socioeconomic status and health: the role of subjective social status","volume":"67","author":"Demakakos","year":"2008","journal-title":"Soc. Sci. Med."},{"issue":"1\u20133","key":"10.1016\/j.schres.2015.08.019_bb0035","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.schres.2007.03.022","article-title":"C-reactive protein is associated with the severity of cognitive impairment but not of psychiatric symptoms in individuals with schizophrenia","volume":"93","author":"Dickerson","year":"2007","journal-title":"Schizophr. Res."},{"issue":"4","key":"10.1016\/j.schres.2015.08.019_bb0040","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1093\/schbul\/sbt113","article-title":"Mortality in schizophrenia: clinical and serological predictors","volume":"40","author":"Dickerson","year":"2014","journal-title":"Schizophr. Bull."},{"issue":"1","key":"10.1016\/j.schres.2015.08.019_bb0045","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.schres.2011.10.003","article-title":"Additive effects of elevated C-reactive protein and exposure to Herpes Simplex Virus type 1 on cognitive impairment in individuals with schizophrenia","volume":"134","author":"Dickerson","year":"2012","journal-title":"Schizophr. Res."},{"issue":"5","key":"10.1016\/j.schres.2015.08.019_bb0050","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1097\/HJR.0b013e328270b913","article-title":"The effects of cigarette smoking on C-reactive protein concentrations in men and women and its modification by exogenous oral hormones in women","volume":"14","author":"Dietrich","year":"2007","journal-title":"Eur. J. Prev. Cardiol."},{"issue":"7","key":"10.1016\/j.schres.2015.08.019_bb0055","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1586\/14737175.7.7.789","article-title":"Inflammation and schizophrenia","volume":"7","author":"Fan","year":"2007","journal-title":"Expert. Rev. Neurother."},{"issue":"1","key":"10.1016\/j.schres.2015.08.019_bb0060","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.psychres.2011.05.010","article-title":"C-reactive protein serum level in drug-free male Egyptian patients with schizophrenia","volume":"190","author":"Fawzi","year":"2011","journal-title":"Psychiatry Res."},{"issue":"3","key":"10.1016\/j.schres.2015.08.019_bb0065","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.psychres.2014.11.057","article-title":"Effect of Ramadan fasting on anthropometric, metabolic, inflammatory and psychopathology status of Egyptian male patients with schizophrenia","volume":"225","author":"Fawzi","year":"2015","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.schres.2015.08.019_bb0070","series-title":"Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition. (SCID-I\/P)","author":"First","year":"2002"},{"issue":"2","key":"10.1016\/j.schres.2015.08.019_bb0080","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0006-3223(00)00240-7","article-title":"Age and neuropsychologic function in schizophrenia: a decline in executive abilities beyond that observed in healthy volunteers","volume":"48","author":"Fucetola","year":"2000","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2015.08.019_bb0085","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.psychres.2011.08.014","article-title":"Inflammatory markers in antipsychotic-naive patients with nonaffective psychosis and deficit vs. nondeficit features","volume":"198","author":"Garcia-Rizo","year":"2012","journal-title":"Psychiatry Res."},{"issue":"5","key":"10.1016\/j.schres.2015.08.019_bb0090","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/S0002-9343(99)00066-2","article-title":"Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly","volume":"106","author":"Harris","year":"1999","journal-title":"Am. J. Med."},{"issue":"2\u20133","key":"10.1016\/j.schres.2015.08.019_bb0105","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.schres.2010.10.029","article-title":"Increased Framingham 10-year risk of coronary heart disease in middle-aged and older patients with psychotic symptoms","volume":"125","author":"Jin","year":"2011","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.schres.2015.08.019_bb0110","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1440-1711.2005.01305.x","article-title":"Immune dysregulation and self-reactivity in schizophrenia: do some cases of schizophrenia have an autoimmune basis?","volume":"83","author":"Jones","year":"2005","journal-title":"Immunol. Cell Biol."},{"issue":"6","key":"10.1016\/j.schres.2015.08.019_bb0115","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1093\/schbul\/sbm140","article-title":"Is schizophrenia a syndrome of accelerated aging?","volume":"34","author":"Kirkpatrick","year":"2008","journal-title":"Schizophr. Bull."},{"issue":"1","key":"10.1016\/j.schres.2015.08.019_bb0120","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/ajpa.22470","article-title":"Significant sex difference in the association between C-reactive protein concentration and anthropometry among 13- to 19-year olds, but not 6- to 12-year olds in Nepal","volume":"154","author":"Konishi","year":"2014","journal-title":"Am. J. Phys. Anthropol."},{"key":"10.1016\/j.schres.2015.08.019_bb0125","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.pnpbp.2013.05.005","article-title":"Obesity and psychiatric disorders: commonalities in dysregulated biological pathways and their implications for treatment","volume":"45","author":"Lopresti","year":"2013","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"6","key":"10.1016\/j.schres.2015.08.019_bb0130","doi-asserted-by":"crossref","first-page":"e573","DOI":"10.4088\/JCP.13m08795","article-title":"Body mass index identified as an independent predictor of psychiatric readmission","volume":"75","author":"Manu","year":"2014","journal-title":"J. Clin. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2015.08.019_bb0135","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3371\/CSRP.MICU.020813","article-title":"C-reactive protein levels in schizophrenia: a review and meta-analysis","volume":"7","author":"Miller","year":"2014","journal-title":"Clin. Schizophr. Relat. Psychoses"},{"key":"10.1016\/j.schres.2015.08.019_bb0140","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.bbi.2014.12.005","article-title":"Total and differential white blood cell counts, high-sensitivity C-reactive protein, and cardiovascular risk in non-affective psychoses","volume":"45","author":"Miller","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.schres.2015.08.019_bb0145","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.numecd.2010.10.010","article-title":"Coronary disease risk prediction algorithm warranting incorporation of C-reactive protein in Turkish adults, manifesting sex difference","volume":"8","author":"Onat","year":"2012","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"10.1016\/j.schres.2015.08.019_bb0155","series-title":"Cognition in Schizophrenia: Impairments, Importance and Treatment Strategies","first-page":"52","article-title":"Executive dysfunction in schizophrenia","author":"Palmer","year":"2000"},{"issue":"1","key":"10.1016\/j.schres.2015.08.019_bb0160","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.schres.2014.07.027","article-title":"Wellness within illness: happiness in schizophrenia","volume":"159","author":"Palmer","year":"2014","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.schres.2015.08.019_bb0165","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1532-5415.1995.tb06377.x","article-title":"Validation of the cumulative illness rating scale in a geriatric residential population","volume":"43","author":"Parmelee","year":"1995","journal-title":"J. Am. Geriatr. Soc."},{"issue":"12","key":"10.1016\/j.schres.2015.08.019_bb0170","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1172\/JCI200318921","article-title":"C-reactive protein: a critical update","volume":"111","author":"Pepys","year":"2003","journal-title":"J. Clin. Investig."},{"issue":"3","key":"10.1016\/j.schres.2015.08.019_bb0175","first-page":"307","article-title":"The prevalence of cardiometabolic risk factors and the ten-year risk of fatal cardiovascular events in patients with schizophrenia and related psychotic disorders","volume":"24","author":"Protopopova","year":"2012","journal-title":"Psychiatr. Danub."},{"issue":"3","key":"10.1016\/j.schres.2015.08.019_bb0180","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/01.CIR.0000053730.47739.3C","article-title":"Clinical application of C-reactive protein for cardiovascular disease detection and prevention","volume":"107","author":"Ridker","year":"2003","journal-title":"Circulation"},{"issue":"21","key":"10.1016\/j.schres.2015.08.019_bb0185","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/j.jacc.2007.02.052","article-title":"C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus","volume":"49","author":"Ridker","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.schres.2015.08.019_bb0190","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s10654-012-9671-0","article-title":"Sex difference and the role of leptin in the association between high-sensitivity C-reactive protein and adiposity in two different populations","volume":"27","author":"Rossi","year":"2012","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.schres.2015.08.019_bb9100","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/sj.ijo.0802939","article-title":"Obesity-related correlation between C-reactive protein and the calculated 10-y Framingham Coronary Heart Disease Risk Score","volume":"29","author":"Rogowski","year":"2005","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.schres.2015.08.019_bb0200","article-title":"Relationship between metabolic syndrome and clinical features, and its personal-social performance in patients with schizophrenia","author":"Saatcioglu","year":"2015","journal-title":"Psychiatry Q."},{"issue":"3","key":"10.1016\/j.schres.2015.08.019_bb0205","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.eurpsy.2011.07.003","article-title":"C-reactive protein as a marker of cardiovascular disease in patients with a schizophrenia spectrum disorder treated in routine medical practice","volume":"28","author":"Sicras-Mainar","year":"2013","journal-title":"Eur. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2015.08.019_bb0215","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1176\/ajp.154.3.371","article-title":"Revisiting the factor structure for positive and negative symptoms: evidence from a large heterogeneous group of psychiatric patients","volume":"154","author":"Toomey","year":"1997","journal-title":"Am. J. Psychiatry"},{"issue":"10","key":"10.1016\/j.schres.2015.08.019_bb0220","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1161\/01.ATV.17.10.2167","article-title":"Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects","volume":"17","author":"Tracy","year":"1997","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"8 Suppl.","key":"10.1016\/j.schres.2015.08.019_bb0225","doi-asserted-by":"crossref","first-page":"C19","DOI":"10.1016\/j.jacc.2005.10.066","article-title":"C-reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patients","volume":"47","author":"Tsimikas","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.schres.2015.08.019_bb0235","first-page":"1","article-title":"Cognitive impairment of executive function as a core symptom of schizophrenia","author":"Wobrock","year":"2008","journal-title":"World J. Biol. Psychiatry"}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092099641500448X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092099641500448X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T15:29:21Z","timestamp":1537370961000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092099641500448X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":42,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S092099641500448X"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2015.08.019","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Associations of high sensitivity C-reactive protein levels in schizophrenia and comparison groups","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2015.08.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}